Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...

Why a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody ...

Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds ...

Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...

The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...

A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...

We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...

International researchers got a reprieve in the courts this week. What does that mean for U.S. medical research? Find out on ...

For all the talk of a hiring spree at the FDA after DOGE cuts last year, the reality is more complicated and filled with ...

FDA's hiring bottleneck, Dems plan for health care oversight, and more from STAT's D.C. Diagnosis newsletter.

Health secretary RFK Jr. returned to his roots in a keynote address at a conference hosted by the Children’s Health Defense, an anti-vaccine nonprofit he helped start.

Researchers have identified a very rare genetic variant that is associated with higher odds of lung cancer in "never smokers." ...